Stanford Mulitple Sclerosis and Neuroimmunology Program News and Events
Walk MS: Silicon Valley 2019. Walk MS is a powerful way to join the movement. The event is Saturday, May 4th in San Jose.
The Stanford Multiple Sclerosis Center announces "Project BIG," the Brain, Immune and Gut Research Initiative to find the cause and cure of Multiple Sclerosis. Project BIG is designed to overcome the inherent difficulties of discovering the mechanisms of MS by inverting traditional paradigms. Using a broad interdisciplinary collaborative model with a tight interface between clinicians and scientists, Project BIG will seek to identify the patient's unique "immuno-fingerprint" as a step toward the true practice of precision medicine. Nearly one million men and women are afflicted with MS nationally.
Jeff Dunn receives 2019 A.B. Baker Teacher Recognition Award
Jeffrey Dunn, MD, Clinical Professor of Neurology and Neurological Sciences was awarded the A.B. Baker Teacher Recognition award. Excellent teachers deserve recognition for their contributions to improving neurology now and in the future. Teaching binds students, residents, faculty, other clinicians, researchers, and even patients, together and helps make our daily work more meaningful. This award demonstrates respect and appreciation for neurologic teaching.
National MS Society Healthcare Partner of the Year Award
Jeffrey Dunn, MD, Clinical Professor of Neurology and Neurological Sciences was awarded the Healthcare Partner of the Year award by the National MS Society.
Stanford MS Center certified by the Consortium of MS Centers
The Stanford Multiple Sclerosis Center was awarded ongoing certification for 2019 as a member Center in good standing with the highly esteemed Consortium of Multiple Sclerosis Centers. Stanford's active membership in the CMSC enables Stanford to continue in its role of national leadership in medical and nursing care in the field of MS.
Stanford neurologist meets with a young general practitioner with MS
A young general practitioner, Sofie van Nues, with a history of Multiple Sclerosis, met with clinical inventor of Natalizumab, Prof. Larry Steinman at 2018 Amsterdam Neuroscience Annual Meeting at Johan Cruijff Arena on October 5, 2018.
Crush MS donates to Stanford
CRUSH MS, a Napa Valley nonprofit organization, donated $50,000 to Stanford University
Local vintners team up to fight multiple sclerosis
Two Napa wineries, Reid Family Vineyards and Counter Punch Wines, have created a grassroots effort dedicated to raising awareness and funds to ensure a world free of multiple sclerosis. Their organization, Crush MS, will hold its annual fundraising event on July 30 at Reid Family Vineyards in Napa.
Research is finding a connection between being overweight at a young age and increased risk of MS
It's known that being overweight can lead to various health problems, including heart disease and type 2 diabetes. Now evidence is building that being overweight early in life might also increase the chance of developing multiple sclerosis (MS) later in life.
Crush MS raises nearly $50,000 for research
Local wineries poured their wines for more than 350 guests at the second annual Crush MS Summer Celebration at Reid Family Vineyards. The event raised nearly $50,000 which will be directed by the National MS Society to Stanford University for research.
Immune response to a flu protein yields new insights into narcolepsy
A swine flu vaccine may have caused rare cases of narcolepsy by stimulating antibodies to attack brain cells that help regulate sleep.
Willow Glen: Girls high school basketball program takes a shot at raising $1k for MS Research
The Willow Glen High School girls basketball program will be hosting a benefit game for Multiple Sclerosis research and awareness and aiming to raise $1,000.
Accelerated Cure Project
The Stanford University MS Center has been selected by the Accelerated Cure Project as one of eight leading national MS Centers to participate in the ACP open access Clinical Research Network.
Immunology: A tolerant approach
Despite a long record of failure, a few immunologists continue to pursue precisely targed therapies for autoimmune disease.
Found: Potential new way to predict some multiple-sclerosis patients’ disease course, drug response
Stanford neurologist May Han, MD, who specializes in MS, encounters questions like these from her patients on a daily basis. MS is an autoimmune disease of the brain and spinal cord that causes paralysis, blindness and other disabling symptoms. Over a million people, most of them young adults in the prime of life, suffer from MS worldwide.